4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0001209191-22-015724
President, R&D sold 8,000 shares at $23.88 ($191,040)
- President, R&D acquired 8,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bergstrom Donald A President, R&D | 2022-03-01 | Option exercise | +8,000 | $4.12 | $32,960 | 102,926 | D |
| Bergstrom Donald A President, R&D | 2022-03-01 | Sale | −8,000 | $23.88 | $191,040 | 94,926 | D |
| Derivatives | |||||||
| Bergstrom Donald A President, R&D | 2022-03-01 | Option exercise · Stock Option (Right to Buy) | −8,000 | 237,456 | D | ||
| Open-market sales · 8,000 sh · avg $23.88 · $191,040 | |||||||
Loading xslF345X03/doc4.xml…